Recruiting

Virtual Reality

Sponsor:

Duke University

Code:

NCT07234201

Conditions

Intensive Care Unit ICU

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Nurse driven virtual reality mobility session

Study Details

Brief summary:

The purpose of this study is to explore if Virtual Reality (VR) helps patients in the Intensive Care Unit (ICU) move more and feel better.

Conditions

Intensive Care Unit ICU

Study ID

NCT07234201

Start date

Dec 1, 2025

Status verified date

Jan, 2026

Completion date

Nov, 2027

Anticipated

Primary completion date

May, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • English speaking
  • Adults age 18 or greater
  • ICU stay greater or equal to 3 days
  • Limited mobility

Exclusion Criteria:

  • Pregnancy
  • Special enteric contact isolation
  • Blindness
  • History of seizure or vertigo
  • Intubated and sedated
  • ICU delirium

Study Design

Enrollment

60 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Supportive Care

Interventions and Outcome Measures

Arms

no intervention: Control

Standard mobility care

other: VR intervention

Virtual Reality

Interventions

Nurse driven virtual reality mobility session

Participants will use the virtual reality device to play the game that will facilitate movement of arms, shoulders and trunk to music, similar to dancing or Tai-Chi.

Primary outcome measure

  • Number of participants with Increased Mobility [ Time Frame: 10 days or ICU discharge, which ever comes first ]

Central Contacts and Locations

Central contacts

Locations

Duke University Hospital

Recruiting

Durham, North Carolina, United States, 27710

Contacts

More Information

Sponsor

Duke University

Last update posted

Jan 12, 2026

Last verified

Jan, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Duke University on 2026-01-12.